<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="//mesenkia.com/wp-content/plugins/wordpress-seo/css/main-sitemap.xsl"?>
<urlset xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd http://www.google.com/schemas/sitemap-image/1.1 http://www.google.com/schemas/sitemap-image/1.1/sitemap-image.xsd" xmlns="http://www.sitemaps.org/schemas/sitemap/0.9">
	<url>
		<loc>https://mesenkia.com/news/</loc>
		<lastmod>2026-07-07T12:56:27+00:00</lastmod>
	</url>
	<url>
		<loc>https://mesenkia.com/news/us-patent-application-ip001-receives-notice-of-allowance/</loc>
		<lastmod>2026-07-07T08:16:33+00:00</lastmod>
	</url>
	<url>
		<loc>https://mesenkia.com/news/international-research-collaboration-brings-hope-for-glioblastoma-treatment/</loc>
		<lastmod>2026-07-07T08:24:36+00:00</lastmod>
	</url>
	<url>
		<loc>https://mesenkia.com/news/kohei-miyazono-new-member-at-the-royal-swedish-academy-of-science/</loc>
		<lastmod>2026-07-07T09:50:43+00:00</lastmod>
	</url>
	<url>
		<loc>https://mesenkia.com/news/almi-invest-invests-in-mesenkia-therapeutics/</loc>
		<lastmod>2026-07-07T09:50:53+00:00</lastmod>
	</url>
	<url>
		<loc>https://mesenkia.com/news/new-preclinical-findings-identify-hvem-as-a-promising-target-in-aggressive-glioblastoma/</loc>
		<lastmod>2026-07-07T12:56:27+00:00</lastmod>
	</url>
</urlset>
<!-- XML Sitemap generated by Yoast SEO -->